A growing number of regulatory challenges are developing surrounding the relatively new practice of combining kratom with OTC medications, often referred to as "kratom lean." Regulators are raising doubts about the likely risks and absence of studies regarding its impact on people's health. Certain analysts contend the combination could cause grave